Transforming Safety In CDMO Operations: A Customer Centric Model For Patients And Employees

In the realm of multimodal CDMOs, the balance between customer satisfaction, worker safety, and product quality is paramount. At FUJIFILM Diosynth Biotechnologies, we believe these three elements are interconnected, with customer-centricity serving as the bridge between safety and quality.

This webinar delves into our unique infrastructure for ensuring safety and quality in drug substance manufacturing. We focus on our new product introduction process, which is underpinned by a robust risk assessment and mitigation framework. Our approach prioritizes:

• Customer-Centric Risk Management: We collaborate closely with customers throughout the manufacturing process to tailor risk management strategies to their specific needs.
• Efficiency and Pragmatism: Our risk assessments focus on optimizing operational efficiency while implementing practical risk mitigation solutions.
• Holistic Approach: We recognize the interconnectedness of safety, quality, and customer satisfaction, ensuring that each element is considered in our decision-making.

Whether you're developing early-stage gene therapy or commercial-scale protein therapeutics, we are committed to partnering with you to deliver safe, high-quality products that meet your specific requirements.